Irina Verbakel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Irina Verbakel has a total of 50 co-authors. Here are the top co-authors by number of shared publications:
Karel Everaert
Department of Urology Ghent University Hospital Ghent Belgium
5 shared publications- François Hervé
Department of Urology, ERN accredited centrum, Ghent University Hospital, Ghent, Belgium
4 shared publications - Karel Everaert
Department of Urology, Ghent University Hospital, Ghent, Belgium
4 shared publications An Mariman
Center for Integrative Medicine, Ghent University Hospital Ghent Belgium
3 shared publicationsDirk Vogelaers
Department of Internal Medicine and Pediatrics Ghent University Hospital Ghent Belgium
3 shared publicationsDonald Bliwise
Department of Neurology Emory University Atlanta Georgia USA
2 shared publications
Latest Publications
- 8 June 2026
- Published by Wiley in Neurourology and Urodynamics
- Vol. 45 (7) , 1405-1412
Deciphering Sleepless Nights: Nocturia Analyzed Through a CART‐Based Predictive Model in Patients With Insomnia. Retrospective Data From the TUCSON Study
Aims: Insomnia and nocturia are prevalent, highly comorbid conditions and share a mutual connection. We aim to further elucidate the link between both in order to improve sleep and eventually overall health. The objective of this analysis was to construct a predictive model for nocturia, using retrospective clinical and polysomnographic data from patients with severe nocturia in line with the TUCSON project: Tackling Underlying Causes Of Sleep Related Nocturia (NCT05404828). Methods: Retrospective data was collected from all adult patients consulting a third line center for insomnia between 2019 and 2021. Data on demographics, medical history, nocturia, insomnia severity index (ISI), Pittsburgh Sleep Quality Index (PSQI), polysomnographic sleep parameters and First Uninterrupted Sleep Period (FUSP) were collected. Potentially significant variables related to nocturia were incorporated into a Classification and Regression Trees (CART) model to predict nocturia using the R “rpart” package. Results: A total of 170 patients presenting with insomnia were analyzed, including 106 without and 64 with nocturia. The median age was 45 years (IQR 31–55), and 58.2% were women. In exploratory CART analyses, FUSP, apnea–hypopnea index (AHI), and REM sleep percentage were identified as potential predictors of nocturia. The predictive model's accuracy was 73.08%, with a sensitivity of 79.41%, specificity of 61.11%, and an ROC area of 0.82. However, logistic regression outperformed CART in internal validation (cross‐validated AUC 0.76 vs. 0.52; bootstrap AUC 0.76 vs. 0.64), and both models showed poor generalization on a held‐out test set. Conclusion: This study is the first to investigate clinical and polysomnographic predictors of nocturia within a select insomnia population. While exploratory CART modeling allowed the identification of potential non‐linear relationships and clinically relevant subgroups, its predictive performance was limited and inferior to logistic regression after internal validation. Although FUSP was not consistently retained across resampled models, its role as a potential contributor to nocturia remains of interest and warrants further investigation in larger, well‐defined cohorts. Trial Registration: ClinicalTrials.gov identifier: NCT05404828.
- 8 June 2026
- Published by Wiley in Neurourology and Urodynamics
- Vol. 45 (7) , 1405-1412
Deciphering Sleepless Nights: Nocturia Analyzed Through a CART‐Based Predictive Model in Patients With Insomnia. Retrospective Data From the TUCSON Study
Aims: Insomnia and nocturia are prevalent, highly comorbid conditions and share a mutual connection. We aim to further elucidate the link between both in order to improve sleep and eventually overall health. The objective of this analysis was to construct a predictive model for nocturia, using retrospective clinical and polysomnographic data from patients with severe nocturia in line with the TUCSON project: Tackling Underlying Causes Of Sleep Related Nocturia (NCT05404828). Methods: Retrospective data was collected from all adult patients consulting a third line center for insomnia between 2019 and 2021. Data on demographics, medical history, nocturia, insomnia severity index (ISI), Pittsburgh Sleep Quality Index (PSQI), polysomnographic sleep parameters and First Uninterrupted Sleep Period (FUSP) were collected. Potentially significant variables related to nocturia were incorporated into a Classification and Regression Trees (CART) model to predict nocturia using the R “rpart” package. Results: A total of 170 patients presenting with insomnia were analyzed, including 106 without and 64 with nocturia. The median age was 45 years (IQR 31–55), and 58.2% were women. In exploratory CART analyses, FUSP, apnea–hypopnea index (AHI), and REM sleep percentage were identified as potential predictors of nocturia. The predictive model's accuracy was 73.08%, with a sensitivity of 79.41%, specificity of 61.11%, and an ROC area of 0.82. However, logistic regression outperformed CART in internal validation (cross‐validated AUC 0.76 vs. 0.52; bootstrap AUC 0.76 vs. 0.64), and both models showed poor generalization on a held‐out test set. Conclusion: This study is the first to investigate clinical and polysomnographic predictors of nocturia within a select insomnia population. While exploratory CART modeling allowed the identification of potential non‐linear relationships and clinically relevant subgroups, its predictive performance was limited and inferior to logistic regression after internal validation. Although FUSP was not consistently retained across resampled models, its role as a potential contributor to nocturia remains of interest and warrants further investigation in larger, well‐defined cohorts. Trial Registration: ClinicalTrials.gov identifier: NCT05404828.
- 18 August 2025
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 21 (6) , 1477-1485
Navigating the waters of LUTS from childhood to puberty – NOPIA meeting (ICI-RS 2024)
- 18 August 2025
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 21 (6) , 1477-1485
Navigating the waters of LUTS from childhood to puberty – NOPIA meeting (ICI-RS 2024)
- 1 April 2025
- Published by Edizioni Minerva Medica in Minerva Urology and Nephrology
- Vol. 77 (2)
From nocturnal awakenings to nocturnal voiding: the relationship between insomnia and nocturia - a systematic review
Article: From nocturnal awakenings to nocturnal voiding: the relationship between insomnia and nocturia - a systematic review - Minerva Urology and Nephrology 2023 Nov 13 - Minerva Medica - Journals
- 1 April 2025
- Published by Edizioni Minerva Medica in Minerva Urology and Nephrology
- Vol. 77 (2)
From nocturnal awakenings to nocturnal voiding: the relationship between insomnia and nocturia - a systematic review
Article: From nocturnal awakenings to nocturnal voiding: the relationship between insomnia and nocturia - a systematic review - Minerva Urology and Nephrology 2023 Nov 13 - Minerva Medica - Journals
- 30 January 2024
- Published by Wiley in Neurourology and Urodynamics
- Vol. 43 (5) , 1134-1146
Is the insomnia phenotype the common denominator in LUTS during transition periods? An expert NOPIA research group review
Aims: As people age, sleep stages and characteristics transition over time, but sleep deficits can profoundly impact health and cognitive functioning. Chronic sleep deprivation is linked to impaired attention and productivity, weakened immunity, increased risk of cardiovascular disease, obesity, and mental health disorders. Insomnia, obstructive sleep apnea syndrome, hormonal changes, nocturia, neurological disorders, and life events interfere with sleep patterns and some are linked to lower urinary tract symptoms (LUTS). This NOPIA symposium on Lifelong LUTS aimed to analyze the literature on associations between sleep and LUTS, generate ideas for future research, and explore whether there is support for the concept of lifelong LUTS in relation to changes in sleep throughout the lifespan.Methods: An international panel of experts took part in an online meeting addressing the role of lifelong LUTS in relationship to sleep and the brain organized by the NOPIA research group. The manuscript summarizes existing literature, hypotheses, future research ideas, and clinical recommendations.Results: Insomnia, sleep fragmentation, hyperarousal, and sensory processing disorders emerged as potential factors in the relationship between sleep and LUTS. Insomnia is often a persistent factor and may have been the initial symptom; however, it is often unrecognized and/or unaddressed in healthcare settings. By recognizing insomnia as a primary driver of various health issues, including nocturia, transitional care aims to address root causes and underlying problems earlier to initiate appropriate treatment.Conclusions: A multidisciplinary approach with collaboration between healthcare professionals from various disciplines, such as urology, sleep medicine, gynecology, pediatrics, and geriatrics, is needed and should include validated measurements such as the insomnia severity index and sleep and voiding diaries. Ensuring ongoing follow‐up and monitoring through transitional care is crucial for individuals with persistent sleep problems and LUTS, allowing issues that arise or fluctuate over the lifespan to be addressed.
- 30 January 2024
- Published by Wiley in Neurourology and Urodynamics
- Vol. 43 (5) , 1134-1146
Is the insomnia phenotype the common denominator in LUTS during transition periods? An expert NOPIA research group review
Aims: As people age, sleep stages and characteristics transition over time, but sleep deficits can profoundly impact health and cognitive functioning. Chronic sleep deprivation is linked to impaired attention and productivity, weakened immunity, increased risk of cardiovascular disease, obesity, and mental health disorders. Insomnia, obstructive sleep apnea syndrome, hormonal changes, nocturia, neurological disorders, and life events interfere with sleep patterns and some are linked to lower urinary tract symptoms (LUTS). This NOPIA symposium on Lifelong LUTS aimed to analyze the literature on associations between sleep and LUTS, generate ideas for future research, and explore whether there is support for the concept of lifelong LUTS in relation to changes in sleep throughout the lifespan.Methods: An international panel of experts took part in an online meeting addressing the role of lifelong LUTS in relationship to sleep and the brain organized by the NOPIA research group. The manuscript summarizes existing literature, hypotheses, future research ideas, and clinical recommendations.Results: Insomnia, sleep fragmentation, hyperarousal, and sensory processing disorders emerged as potential factors in the relationship between sleep and LUTS. Insomnia is often a persistent factor and may have been the initial symptom; however, it is often unrecognized and/or unaddressed in healthcare settings. By recognizing insomnia as a primary driver of various health issues, including nocturia, transitional care aims to address root causes and underlying problems earlier to initiate appropriate treatment.Conclusions: A multidisciplinary approach with collaboration between healthcare professionals from various disciplines, such as urology, sleep medicine, gynecology, pediatrics, and geriatrics, is needed and should include validated measurements such as the insomnia severity index and sleep and voiding diaries. Ensuring ongoing follow‐up and monitoring through transitional care is crucial for individuals with persistent sleep problems and LUTS, allowing issues that arise or fluctuate over the lifespan to be addressed.
- 25 January 2024
- Published by Wiley in Neurourology and Urodynamics
- Vol. 43 (5) , 1058-1065
The cost of lifelong LUTS—A systematic literature review
Background: Lower urinary tract symptoms (LUTS) are highly prevalent and very bothersome. To support the best possible allocation of health care resources and to avoid unnecessary expenditures, it is important to understand and quantify the wide‐ranging health care costs affecting people suffering from LUTS. We aimed at creating a foundation for exploring the cost of LUTS.Method: In this systematic literature review, we explored the costs of illness of the LUTS umbrella. We used the online literature review tool Silvi.ai for transparent decision‐making and literature management.Results: A total of 1821 original articles were screened. Forty had explored the cost of illness of a LUTS disease since 2013. The studies were conducted in 18 countries. A number of different study designs were applied, including both retrospective and prospective studies. In total, seven LUTS indications were explored. None of them focused on lifelong LUTS. None of them were conducted in infants or children. Eighty‐two percent were conducted in adults and 18% in frail elderly. Most cost of illness studies focused on the cost of hospitalization and use of medicine.Conclusion: We have created the groundwork for understanding the cost of LUTS illness. To fully understand the cost of illness of lifelong LUTS, the main gap in research is to investigate the cost of LUTS in infants and children.
- 25 January 2024
- Published by Wiley in Neurourology and Urodynamics
- Vol. 43 (5) , 1058-1065
The cost of lifelong LUTS—A systematic literature review
Background: Lower urinary tract symptoms (LUTS) are highly prevalent and very bothersome. To support the best possible allocation of health care resources and to avoid unnecessary expenditures, it is important to understand and quantify the wide‐ranging health care costs affecting people suffering from LUTS. We aimed at creating a foundation for exploring the cost of LUTS.Method: In this systematic literature review, we explored the costs of illness of the LUTS umbrella. We used the online literature review tool Silvi.ai for transparent decision‐making and literature management.Results: A total of 1821 original articles were screened. Forty had explored the cost of illness of a LUTS disease since 2013. The studies were conducted in 18 countries. A number of different study designs were applied, including both retrospective and prospective studies. In total, seven LUTS indications were explored. None of them focused on lifelong LUTS. None of them were conducted in infants or children. Eighty‐two percent were conducted in adults and 18% in frail elderly. Most cost of illness studies focused on the cost of hospitalization and use of medicine.Conclusion: We have created the groundwork for understanding the cost of LUTS illness. To fully understand the cost of illness of lifelong LUTS, the main gap in research is to investigate the cost of LUTS in infants and children.
- 9 November 2023
- Published by Wiley in Neurourology and Urodynamics
- Vol. 43 (6) , 1391-1399
How should we assess the cardiovascular system in patients presenting with bothersome nocturia? ICI‐RS 2023
Aims: The link between nocturia and cardiovascular disease (CVD) is frequently discussed in literature, yet the precise nature of this relationship remains poorly characterized. The existing literature was reviewed in order to address issues concerning the origin, diagnosis, management, and implications of the co‐occurrence of CVD and nocturia.Methods: This review summarizes literature and recommendations regarding the link between CVD and nocturia discussed during a think‐tank meeting held at the 2023 International Consultation on Incontinence‐Research Society.Results: Cardiovascular disorders are often underestimated contributors to nocturia, with various potential mechanisms influencing nighttime urination, such as impact on fluid retention, atrial natriuretic peptide, and glomerular filtration rate. The redistribution of fluid from leg edema in supine position can lead nocturnal polyuria (NP). Additionally, sleep disturbances due to nocturia in itself may lead to CVD through an increase in blood pressure, insulin resistance, and inflammation. Disrupted circadian rhythms (e.g., in sleep pattern and urine production) were identified as critical factors in most etiologies of nocturia, and their contribution is deemed imperative in future research and treatment approaches, particularly in the aging population. NP can be detected through a simple bladder diary and can even be used to distinguish cardiac from noncardiac causes of nocturia. For the treatment of NP, desmopressin can be effective in select patients, however, caution and close monitoring is warranted for those with CVD due to increased risk of side effects.Conclusions: Gaps were identified in the available evidence and clear cut recommendations were put forth for future research. It is essential to gain a deeper understanding of the mechanisms linking nocturia and CVD to develop optimal management strategies.
- 9 November 2023
- Published by Wiley in Neurourology and Urodynamics
- Vol. 43 (6) , 1391-1399
How should we assess the cardiovascular system in patients presenting with bothersome nocturia? ICI‐RS 2023
Aims: The link between nocturia and cardiovascular disease (CVD) is frequently discussed in literature, yet the precise nature of this relationship remains poorly characterized. The existing literature was reviewed in order to address issues concerning the origin, diagnosis, management, and implications of the co‐occurrence of CVD and nocturia.Methods: This review summarizes literature and recommendations regarding the link between CVD and nocturia discussed during a think‐tank meeting held at the 2023 International Consultation on Incontinence‐Research Society.Results: Cardiovascular disorders are often underestimated contributors to nocturia, with various potential mechanisms influencing nighttime urination, such as impact on fluid retention, atrial natriuretic peptide, and glomerular filtration rate. The redistribution of fluid from leg edema in supine position can lead nocturnal polyuria (NP). Additionally, sleep disturbances due to nocturia in itself may lead to CVD through an increase in blood pressure, insulin resistance, and inflammation. Disrupted circadian rhythms (e.g., in sleep pattern and urine production) were identified as critical factors in most etiologies of nocturia, and their contribution is deemed imperative in future research and treatment approaches, particularly in the aging population. NP can be detected through a simple bladder diary and can even be used to distinguish cardiac from noncardiac causes of nocturia. For the treatment of NP, desmopressin can be effective in select patients, however, caution and close monitoring is warranted for those with CVD due to increased risk of side effects.Conclusions: Gaps were identified in the available evidence and clear cut recommendations were put forth for future research. It is essential to gain a deeper understanding of the mechanisms linking nocturia and CVD to develop optimal management strategies.
- 6 November 2023
- Published by Wiley in Neurourology and Urodynamics
- Vol. 43 (5) , 1147-1154
First uninterrupted sleep period in children and adolescents with nocturnal enuresis: Added value in diagnosis and follow‐up during therapy
Background: The first uninterrupted sleep period (FUSP, time up to the first episode of enuresis/nocturia after falling asleep) is a frequently investigated parameter in adults with nocturia, as it correlates with quality of life. However, it has not been included in pediatric enuresis studies.Aim: Investigate FUSP, circadian renal water and sodium handling, as well as sleep quality before and after desmopressin therapy in enuresis.Materials and Methods: We conducted a post hoc analysis of a prospective study in 30 treatment‐naïve children with enuresis who underwent a video‐polysomnography and a 24‐h urine concentration profile before and after 6 months of desmopressin therapy. We analyzed FUSP, periodic limb movements in sleep (PLMS), and arousal indexes and their correlations with the urinary parameters.Results: Sixteen children with a mean age of 10.9 ± 3.1 years had full registrations and were included in this subanalysis. After therapy, FUSP was significantly longer (p < 0.001), and the PLMS index was lower (p = 0.023). Significant differences in the circadian rhythm of diuresis (night/day diuresis, p = 0.041), nocturnal urinary osmolality (p = 0.009), and creatinine (p = 0.001) were found, demonstrating the increase of urinary concentration overnight by desmopressin, as well as a significant antidiuretic effect (diuresis [p = 0.013] and diuresis rate (p = 0.008). There was no correlation between the difference of FUSP, PLMS index, and urinary parameters. Nevertheless, despite this study being underpowered, there are indications of a correlation between nocturnal diuresis and diuresis rate.Results: Our results support the need for further research regarding FUSP in children with enuresis, in accordance with nocturia studies in adults, as this parameter could be valuable in the follow‐up and evaluation of therapeutic strategies for enuresis.
- 6 November 2023
- Published by Wiley in Neurourology and Urodynamics
- Vol. 43 (5) , 1147-1154
First uninterrupted sleep period in children and adolescents with nocturnal enuresis: Added value in diagnosis and follow‐up during therapy
Background: The first uninterrupted sleep period (FUSP, time up to the first episode of enuresis/nocturia after falling asleep) is a frequently investigated parameter in adults with nocturia, as it correlates with quality of life. However, it has not been included in pediatric enuresis studies.Aim: Investigate FUSP, circadian renal water and sodium handling, as well as sleep quality before and after desmopressin therapy in enuresis.Materials and Methods: We conducted a post hoc analysis of a prospective study in 30 treatment‐naïve children with enuresis who underwent a video‐polysomnography and a 24‐h urine concentration profile before and after 6 months of desmopressin therapy. We analyzed FUSP, periodic limb movements in sleep (PLMS), and arousal indexes and their correlations with the urinary parameters.Results: Sixteen children with a mean age of 10.9 ± 3.1 years had full registrations and were included in this subanalysis. After therapy, FUSP was significantly longer (p < 0.001), and the PLMS index was lower (p = 0.023). Significant differences in the circadian rhythm of diuresis (night/day diuresis, p = 0.041), nocturnal urinary osmolality (p = 0.009), and creatinine (p = 0.001) were found, demonstrating the increase of urinary concentration overnight by desmopressin, as well as a significant antidiuretic effect (diuresis [p = 0.013] and diuresis rate (p = 0.008). There was no correlation between the difference of FUSP, PLMS index, and urinary parameters. Nevertheless, despite this study being underpowered, there are indications of a correlation between nocturnal diuresis and diuresis rate.Results: Our results support the need for further research regarding FUSP in children with enuresis, in accordance with nocturia studies in adults, as this parameter could be valuable in the follow‐up and evaluation of therapeutic strategies for enuresis.
- Open Access
- 6 May 2023
- Published by Elsevier in Continence
- Vol. 6
The short-term false positives after sacral neuromodulation therapy: Who, how many and why? A prospective descriptive single centre study
- 6 May 2023
- Published by Elsevier in Continence
- Vol. 6
Open AccessThe short-term false positives after sacral neuromodulation therapy: Who, how many and why? A prospective descriptive single centre study
- 2 November 2022
- Published by Wiley in Neurourology and Urodynamics
- Vol. 42 (1) , 303-308
Laying the foundation for enhancing safety of desmopressin in older people: Validation of capillary blood sodium levels
Purpose: We aim to make desmopressin a safe treatment option for (older) patients at risk for hyponatremia, by introducing a new way of sodium monitoring. The goal is to reduce the risk of hyponatremia, enhance patient safety and ultimately introduce self‐monitoring of sodium levels. The first step in the aforementioned is to validate capillary sodium.Materials and Methods: 100 randomly selected patients admitted to the urology department received a single finger prick to collect capillary blood (250 µl) in a lithium‐heparin tube. Each patient acted as its own control for the capillary and venous blood sample. Venous and capillary plasma sodium were analyzed by indirect ion‐selective electrode measurement. The primary outcome was the agreement between capillary and venous sodium measurements, measured by the intra‐class correlation coefficient (ICC).Results: One hundred paired blood samples were obtained of which four were excluded. There was no significant statistical difference observed between venous and capillary sodium (−0.23 mmol/L, p = 0.374). The ICC for single measures between capillary and venous sodium was 0.82 (95% confidence interval 0.75–0.88). Inter‐method differences analyzed by a Bland–Altman plot and a Passing–Bablock regression did not reveal a statistically significant difference between both groups.Conclusions: We demonstrated that venous and capillary sodium levels are interchangeable, taken into account the inter‐ and intravariability between analyses. We provided the first step towards a simple and safe solution for frequent sodium monitoring through a minimal invasive capillary blood collection. The results are of direct clinical relevance to safely use desmopressin in (older) patients at risk.
- 2 November 2022
- Published by Wiley in Neurourology and Urodynamics
- Vol. 42 (1) , 303-308
Laying the foundation for enhancing safety of desmopressin in older people: Validation of capillary blood sodium levels
Purpose: We aim to make desmopressin a safe treatment option for (older) patients at risk for hyponatremia, by introducing a new way of sodium monitoring. The goal is to reduce the risk of hyponatremia, enhance patient safety and ultimately introduce self‐monitoring of sodium levels. The first step in the aforementioned is to validate capillary sodium.Materials and Methods: 100 randomly selected patients admitted to the urology department received a single finger prick to collect capillary blood (250 µl) in a lithium‐heparin tube. Each patient acted as its own control for the capillary and venous blood sample. Venous and capillary plasma sodium were analyzed by indirect ion‐selective electrode measurement. The primary outcome was the agreement between capillary and venous sodium measurements, measured by the intra‐class correlation coefficient (ICC).Results: One hundred paired blood samples were obtained of which four were excluded. There was no significant statistical difference observed between venous and capillary sodium (−0.23 mmol/L, p = 0.374). The ICC for single measures between capillary and venous sodium was 0.82 (95% confidence interval 0.75–0.88). Inter‐method differences analyzed by a Bland–Altman plot and a Passing–Bablock regression did not reveal a statistically significant difference between both groups.Conclusions: We demonstrated that venous and capillary sodium levels are interchangeable, taken into account the inter‐ and intravariability between analyses. We provided the first step towards a simple and safe solution for frequent sodium monitoring through a minimal invasive capillary blood collection. The results are of direct clinical relevance to safely use desmopressin in (older) patients at risk.